Case Report

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports

Figure 2

Bone marrow aspirate (×1000, panoptical staining) after 13 AZA cycles; myeloblasts and monoblasts, progression to AML (60% of myeloblasts).
369086.fig.002